22 articles
Two-thirds of cannabis drink users reported drinking less alcohol, with most also seeing better sleep, mood, and reduced stress, a new study finds.
A federal judge will decide whether marijuana rescheduling moves cannabis from Schedule I to III, potentially reshaping access for six million medical.
FDA warning letters hit a 3-year high in 2026, with marketing claims on websites and social media now driving supplement enforcement as hard as factory.
Cannabis hyperemesis syndrome cases rose 16%, and doctors now see it in users under one year of use, driven by today's ultra-high-potency THC products.
Kratom poisoning cases surged 1,200% since 2015, yet a new lawsuit reveals the supplement still lacks FDA oversight or addiction warnings.
The FDA is warning again that weight loss supplements containing toxic yellow oleander, which can cause fatal heart problems, may still be on store.
Congress delayed the federal hemp THC ban until December, giving lawmakers time to craft regulations instead of prohibition in a 90-to-6 Senate vote.
A new review of 70 studies finds CBD may reduce inflammation, pain, and anxiety in athletes, with major sports leagues already relaxing cannabis policies.
A White House drug official claims marijuana kills Americans, but federal DEA data shows zero overdose deaths have ever been recorded from cannabis.
An FDA panel voted to allow six unapproved peptides in compounding pharmacies despite safety warnings, raising concerns about patient risk.
CBD users with epilepsy reported fewer ER visits, better sleep, and lower anxiety, suggesting doctors should guide older adults toward monitored.
A bipartisan hemp regulation bill proposes age limits, testing rules, and THC taxes before stricter federal restrictions take effect November 12, 2026.
The FTC is cracking down on wellness fraud, targeting supplement makers, telehealth firms, and influencers with millions in fines and consumer refunds.
Moringa supplements have triggered eight FDA recalls this year, exposing a regulatory gap that lets contaminated products reach shelves before safety.
THC drinks sold next to sodas have driven a 13,000% rise in child cannabis poisonings, as minimal labeling leaves buyers unable to tell them apart.
A THC and CBD combination reduced agitation in 87% of dementia patients in a new trial, offering a safer alternative to antipsychotics for end-of-life.
The ACP is calling for sweeping FDA supplement reforms, citing 79,000 adverse event reports and nearly 100,000 products sold with no premarket safety.
Federal cannabis rescheduling moved medical cannabis to Schedule III, unlocking faster research and potential tax relief for patients and businesses.
Mindfulness-based group therapy cut stress, anxiety, and depression in advanced cancer patients, with benefits lasting two months after the program ended.
The FTC sued WPATH, alleging its transgender youth treatment guidelines made false safety claims to parents, with no evidence the procedures reduce.
A single cup of peppermint tea improved memory in four cognitive tests and increased brain blood flow in a small 25-person clinical trial.
WHO unveils a 10-year plan to integrate traditional medicine into global health systems, backed by 179 nations and evidence-based standards.
